- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 475/00 - Heterocyclic compounds containing pteridine ring systems
Patent holdings for IPC class C07D 475/00
Total number of patents in this class: 187
10-year publication summary
|
11
|
9
|
12
|
12
|
10
|
10
|
6
|
12
|
13
|
8
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Boehringer Ingelheim International GmbH | 4646 |
17 |
| Vertex Pharmaceuticals Incorporated | 1627 |
9 |
| Amgen Inc. | 4105 |
8 |
| Blueprint Medicines Corporation | 238 |
8 |
| East China University of Science and Technology | 520 |
7 |
| Astex Therapeutics Limited | 242 |
4 |
| Chroma Therapeutics Ltd. | 36 |
4 |
| Dana-Farber Cancer Institute, Inc. | 2593 |
4 |
| Gilead Sciences, Inc. | 2049 |
4 |
| Janus Biotherapeutics, Inc. | 10 |
4 |
| Abbisko Therapeutics Co., Ltd. | 110 |
4 |
| Vigil Neuroscience, Inc. | 46 |
4 |
| AstraZeneca AB | 2895 |
3 |
| AstraZeneca UK Limited | 628 |
3 |
| Pfizer Inc. | 3375 |
3 |
| CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. | 192 |
3 |
| Signal Pharmaceuticals, LLC | 181 |
3 |
| Genentech, Inc. | 4001 |
2 |
| University of Florida Research Foundation, Inc. | 4048 |
2 |
| Purdue Research Foundation | 3670 |
2 |
| Other owners | 89 |